期刊文献+

p53和血管内皮生长因子表达与胃癌血管生成的关系 被引量:2

Relationship of p53 and VEGF Expression with Tumor Angiogenesis in Gastric Carcinoma
下载PDF
导出
摘要 目的 :探讨p5 3和血管内皮生长因子表达与胃癌血管生成的关系。方法 :应用免疫组织化学方法检测 76例胃癌组织的p5 3蛋白、血管内皮生长因子 (VEGF)与微血管密度 (MVD)表达 ,分析p5 3蛋白、VEGF及MVD表达与临床病理指标之间的关系。结果 :胃癌组织p5 3蛋白与VEGF阳性表达率分别为 4 2 1% (32 76)和 38 2 % (2 9 76) ,MVD平均计数为 36 6± 17 2 ( x±s) ;p5 3、VEGF、MVD表达与肿瘤浸润深度 (P <0 0 5 ,P <0 .0 1,P <0 .0 5 )、淋巴结转移 (P <0 0 1,P <0 0 5 ,P <0 0 1)和远处转移 (P <0 0 1,P <0 0 1,P <0 0 1)密切相关 ;p5 3蛋白与VEGF表达密切相关 (χ2 =35 3916,P <0 0 1,P <0 0 1)。结论 :VEGF与MVD表达是反映胃癌生物学行为的重要标志 ,p5 Objective To explore the relationship of p53 and vascular endothelial growth factor(VEGF) with tumor angiogenesis in gastric carcinoma.Methods Expression of p53,VEGF and MVD (microvessel density) were examined immunohistochemically in 76 gastric carcinoma specimens,correlation among the expression of p53,VEGF and MVD and various clinicopathologic factors were also analysed.Results The expression rate of p53 and VEGF in gastric carcinoma were 42.1% and 38.2% respectively,the mean value of MVD was 36.6±17.2(±s).Statistics analysis revealed that overexpression of p53,VEGF and MVD were correlated positively with the pathologic factors such as invasive depth,lymph node involvement and metastasis to liver.Furthermore,the over expression of p53 was correlated positively with VEGF.Conclusions p53 may contribute to tumor angiogenesis by means of up-regulation of VEGF.The overexpression of p53,VEGF and MVD in gastric carcinoma were correlated positively with severity of invasive depth,lymph node involvement and metastasis to distal organs,thus may serve as the poor indicators of prognosis in gastric carcinoma.
出处 《肿瘤防治杂志》 2003年第2期148-150,共3页 China Journal of Cancer Prevention and Treatment
关键词 胃肿瘤 蛋白质P53 新生血管化 病理性 内皮生长因子 免疫组织化学 血管生成 gastric neoplasms protein 53 neovascularization,pathologyic endothelial growth factors immunohistochemistry
  • 相关文献

参考文献9

  • 1[1]Folkman J. What is the evidence that tumors are angiogenesis depen dent?[J].J Natl Cancer Inst,1990,82(1):4-6.
  • 2[2]Mukhopadhyay D,Tsiokas L,Sukhatme VP. Wild-type p53 and v-Src ex e rt opposing influences on human vascular endothelial growth factor gene expressi on[J].Cancer Res,1995,55(24):6161-6165.
  • 3[3]Bosari S,Lee AK,DeLellis RA,et al. Microvessel quantitation and pr o gnosis in invasive breast carcinoma[J].Hum Pathol,1992,23(7):755-761.
  • 4[4]Kakeji Y,Korenaga D,Tsujitani S,et al. Gastric cancer with p53 ove r expression has high potential for metastasising to lymph nodes[J].Br J Cancer, 1993,67(3):589-593.
  • 5[5]Kieser A,Weich HA,Brandner G,et al. Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression[J].Oncoge ne,1994,9(3):963-969.
  • 6[6]Riccioni T,Cirielli C,Wang X,et al. Adenovirus-mediated wild-typ e p53 overexpression inhibits endothelial cell differentiation in vitro and angio genesis in vivo[J].Gene Ther,1998,5(6):747-754.
  • 7[7]Bouvet M,Ellis LM,Nishizaki M,et al. Adenovirus-mediated wild-ty p e p53 gene transfer down-regulates vascular endothelial growth factor expressio n and inhibits angiogenesis in human colon cancer[J].Cancer Res,1998,58(11):22 88-2292.
  • 8[8]Linderholm BK,Lindahl T,Holmberg L,et al. The expression of vascular endothelial growth factor correlates with mutant p53 and poor prognosis in human breast cancer[J].Cancer Res,2001,61(5):2256-2260.
  • 9[9]Toi M,Hoshina S,Takayanagi T,et al. Association of vascular endoth e lial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer[J].Jpn J Cancer Res,1994,85(10):1045-1049.

同被引文献11

  • 1Mattern J, Koomagi R, Volm M. Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumor cell proliferation in human epidermoid lung carcinoma[J]. Br J Cancer, 1996,73(7) :931-934.
  • 2Weidner N, Semple J P, Welch W R, et al. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma [J]. N Engl J Med, 1991,324(1) :1-8.
  • 3Yamasaki F, Yoshioka H, Hama S, et al. Recurrence of meningiomas[J]. Cancer, 2000, 89(5) :1102-1110.
  • 4Geisler S A, Olshan A F, Weissler M C, et al. p16 and p53 Protein expression as prognostic indicators of survival and disease recurrence from head and neck cancer[J]. Clin Cancer Res,2002, 8(11) :3445-3453.
  • 5Zheng M H, Xu J, Robbins P, et al. Gene expression of vascular endothelial growth factor in giant cell tumors of bone[J].Hum Pathol, 2000, 31(7) :804-812.
  • 6Mukhopadhyay D, Tsiokas L, Sukhatme V P, et al. Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression[J]. Cancer Res, 1995,55(24) :6161-6165.
  • 7Fontanini G, Vignati S, Lucchi M, et al. Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor(VEGF) expression[J]. BrJCancer, 1997, 75(9) :1295-1301.
  • 8Maeda K,Chung Y S,Ogawa Y,et al.Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma[J].Br J Cancer,1996,73(8):884-888.
  • 9Takebayashi Y,Miyadera K,Akiyama S,et al.Expression of thymidine phosphorylase in human gastric carcinoma[J].Jpn J Cancer Res,1996,87(3):288-295.
  • 10Ikeda M,Furukawa H,Imamura H,et al.Poor prognosis associated with thrombocytosis in patients with gastric cancer[J].Ann Surg Oncol,2002,9:287-291.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部